Free Trial

TC Biopharm (TCBPW) Competitors

TC Biopharm logo
$0.02 +0.01 (+94.00%)
(As of 02:22 PM ET)

TCBPW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDW

Should you be buying TC Biopharm stock or one of its competitors? The main competitors of TC Biopharm include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.

TC Biopharm vs.

TC Biopharm (NASDAQ:TCBPW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

TC Biopharm and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
TC BiopharmN/AN/A
180 Life SciencesN/AN/A

In the previous week, TC Biopharm's average media sentiment score of 1.89 beat 180 Life Sciences' score of 1.87 indicating that TC Biopharm is being referred to more favorably in the media.

Company Overall Sentiment
TC Biopharm Very Positive
180 Life Sciences Very Positive

Company Net Margins Return on Equity Return on Assets
TC BiopharmN/A N/A N/A
180 Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TC Biopharm$2.86MN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

TC Biopharm beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TCBPW vs. The Competition

MetricTC BiopharmBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$202.92M$5.15B$9.28B
Dividend YieldN/A3.54%4.81%4.06%
P/E RatioN/A317.19135.4217.51
Price / SalesN/A15,267.141,184.62142.21
Price / CashN/A11.6740.4237.95
Price / BookN/A7.264.894.94
Net IncomeN/A-$18.52M$118.71M$225.59M
7 Day PerformanceN/A185.66%15.74%-1.07%
1 Month PerformanceN/A133.72%15.70%7.23%
1 Year PerformanceN/A113.83%34.85%22.97%

TC Biopharm Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TCBPW
TC Biopharm
N/A$0.02
+94.0%
N/A-50.0%$0.00$2.86M0.0080Gap Up
High Trading Volume
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A+41.0%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/AGap Down
AEHAW
Aesther Healthcare Acquisition
N/A$0.04
flat
N/A+4.1%$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.05
+142.2%
N/AN/A$0.00$40,633.000.0040Positive News
ALVOW
Alvotech
N/A$2.50
-3.8%
N/A+12.9%$0.00$391.87M0.004Gap Up
ALVO
Alvotech
2.7632 of 5 stars
$11.28
-1.1%
$18.00
+59.6%
+13.9%$0.00$93.38M-6.101,026
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.04
+29.0%
N/AN/A$0.00N/A0.004
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$8.05
-26.8%
N/AN/A$0.00N/A0.004Gap Down
BFRIW
Biofrontera
N/A$0.11
+9.8%
N/A+263.0%$0.00$35.36M0.0070Positive News
BTMDW
biote
N/A$0.45
+2.3%
N/AN/A$0.00$193.06M0.00N/A

Related Companies and Tools


This page (NASDAQ:TCBPW) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners